GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocon Ltd (NSE:BIOCON) » Definitions » Other Operating Expense

Biocon (NSE:BIOCON) Other Operating Expense : ₹77,547 Mil (TTM As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Biocon Other Operating Expense?

Biocon's Other Operating Expense for the three months ended in Mar. 2024 was ₹20,991 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹77,547 Mil.

Biocon's quarterly Other Operating Expense declined from Sep. 2023 (₹19,869 Mil) to Dec. 2023 (₹18,072 Mil) but then increased from Dec. 2023 (₹18,072 Mil) to Mar. 2024 (₹20,991 Mil).

Biocon's annual Other Operating Expense increased from Mar. 2022 (₹34,921 Mil) to Mar. 2023 (₹50,748 Mil) and increased from Mar. 2023 (₹50,748 Mil) to Mar. 2024 (₹76,518 Mil).


Biocon Other Operating Expense Historical Data

The historical data trend for Biocon's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocon Other Operating Expense Chart

Biocon Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25,967.00 31,372.00 34,921.00 50,748.00 76,518.00

Biocon Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,584.00 18,615.00 19,869.00 18,072.00 20,991.00

Biocon Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹77,547 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biocon Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Biocon's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Biocon (NSE:BIOCON) Business Description

Traded in Other Exchanges
Address
20th KM, Hosur Road, Electronics City, Bengaluru, KA, IND, 560 100
Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Generics, Biosimilars, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene.

Biocon (NSE:BIOCON) Headlines

No Headlines